Related Experiment Videos
Latex allergy in spina bifida patients--prevention by primary prophylaxis
R Cremer1, U Kleine-Diepenbruck, A Hoppe
1Children's Hospital, Paediatric Clinic, Cologne, Germany.
Insights
Primary latex prophylaxis during surgery prevents latex allergy in children with spina bifida. This intervention is crucial for this high-risk group, significantly reducing sensitization rates.
Area of Science:
- Pediatric Surgery
- Allergy and Immunology
- Neurosurgery
Background:
- Children with spina bifida are a high-risk group for latex allergy.
- Repeated surgeries increase the risk of latex sensitization in this population.
- The efficacy of latex prophylaxis in spina bifida patients has not been previously studied.
Purpose of the Study:
- To determine if primary latex prophylaxis during surgery can prevent latex allergy in children with spina bifida.
- To assess the impact of latex-free surgical environments on latex sensitization rates.
Main Methods:
- Established latex-free surgery and anesthesia for all spina bifida patients starting December 1995.
- Monitored specific IgE against latex in children born after the protocol implementation.
- Compared sensitization rates with a historical cohort of spina bifida patients.
Main Results:
- Before prophylaxis, 38% of spina bifida children (3/7) were sensitized to latex by age 2.
- After implementing latex-free protocols, none of the 12 studied patients developed latex sensitization.
- This was observed despite some patients undergoing up to seven operations.
Conclusions:
- Primary latex prophylaxis during surgery is effective in preventing latex sensitization in young spina bifida patients.
- Implementing latex-free surgical practices is a critical measure for this vulnerable population.
Background:
The effect of latex prophylaxis has not been investigated in spina bifida children, a high-risk group for latex allergy. As repeated operations have been identified as a major cause of latex sensitization, we wanted to find out whether primary latex prophylaxis during surgery could prevent latex allergy in children with spina bifida.
Methods:
In December 1995, we established latex-free surgery and anesthesia for all patients with spina bifida regardless of their sensitization to latex. Twelve children born after that date (mean age 1.2 years, mean number of operations 3.3, range 1-7) were tested for specific IgE against latex until December 1997 (ImmunoCap, Pharmacia, Uppsala, Sweden) and compared with eight children born before December 1995 (mean age 1.3 years, mean number of operations 3.6, range 1-8), in whom a test for latex IgE had been done before the age of 2 years.
Results:
Before we established primary prophylaxis, three of seven children with spina bifida (38%) were sensitized to latex until the age of 2 years. After the establishment of a latex-free operating theater for spina bifida patients, none of the 12 patients were sensitized to latex despite up to seven operations in each child.
Conclusions:
Primary latex prophylaxis during surgery can prevent latex sensitization in young spina bifida patients.